Liver Cancer Awareness Month 2025: Insights from BMC Series Journals
Published in Cancer, General & Internal Medicine, and Public Health
Liver Cancer Awareness Month is celebrated each year in October to create public awareness about liver cancer, its symptoms, risk factors, and prevention methods. According to the World Health Organization (WHO), liver cancer ranks among the top three causes of cancer-related deaths globally, responsible for more than 800,000 deaths each year. This year’s campaign “Liver Cancer Doesn’t Discriminate,” serves as a reminder that liver cancer can affect anyone, regardless of age, gender, or background and highlights the importance of liver health in everyday life.
In this blog, we spotlight recent publications from the BMC Series journals, including BMC Cancer, BMC Gastroenterology, and BMC Psychiatry, that explore how metabolism, lifestyle, and mental wellbeing influence the occurrence and recurrence of liver cancer.
BMC Cancer – Basal metabolic rate shapes the development and progression of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common types of primary liver cancer. A study published in BMC Cancer explores how the basal metabolic rate (BMR) influences the development and progression of HCC. Using a customized animal model, the researchers compared two lines of laboratory mice divergently selected for BMR. When liver cancer was chemically induced, the high-BMR mice developed tumors faster, showed greater disease progression, and had larger, more active livers than their low-BMR group.
The study suggests that a genetically determined high BMR may put extra stress on liver cells, activating certain metabolism-related genes that can drive tumor formation. It also highlights how biological factors, such as genetics, and environmental, such as diet and nutrient intake shape cancer risks. The study further reinforces the importance of maintaining metabolic health through balanced nutrition, exercise, and routine check-ups, to reduce the risk of liver cancer.
BMC Gastroenterology – Liver cancer risk and changes in lifestyle habits after successful hepatitis C virus therapy post-DAA)
Hepatitis C virus (HCV) infection is the leading cause of chronic liver disease, fibrosis, and cirrhosis conditions that can eventually lead to hepatocellular carcinoma. The introduction of direct-acting antiviral (DAA) therapy has revolutionized treatment by curing most cases of HCV. However, a recent study published in BMC Gastroenterology reveals that post-cure lifestyle habits can affect long-term outcomes.
In this questionnaire-based study, researchers assessed individuals who had been cured of HCV using DAA combinations to understand how their daily habits changed post-treatment. Participants who become more relaxed about their health and shifted to unhealthy habits such as alcohol consumption, gained weight, and had a sedentary lifestyle were observed having slightly increased risk of liver-related complications, even after the virus was cleared.
The authors emphasized the importance of lifestyle counseling and regular monitoring for these patients after HCV treatment. The prevalence of obesity and low physical activity among the cohort also highlights the need for targeted prevention strategies. This study highlights that liver health requires lifelong care. Staying active, eating well, avoiding alcohol, and attending follow-ups are essential for preventing disease recurrence.
Cancer patients often experience chronic stress as they navigate diagnosis and treatment, leading to insomnia, anxiety, and emotional strain. A recent study published in BMC Psychiatry explored how chronic stress affects survival outcomes in patients who had undergone curative treatment for HCC.
The researchers developed an innovative Chronic Stress Index (CSI) combining three measures - hair cortisol concentration (a biomarker of long-term stress), a Stress Score derived from physiological readings, and the Perceived Stress Scale (PSS-10) questionnaire. Using this index, they categorized patients based on their stress levels and compared disease-free survival (DFS) and overall survival (OS). The results showed that patients with higher CSI scores had significantly shorter DFS and OS compared to those with lower stress levels. Chronic stress weakens the body’s immune system, disrupts hormone balance, and promotes inflammation - all of which can lead to cancer recurrence.
By recognizing stress as a clinical factor, healthcare professionals can provide personalized psychological support, helping patients strengthen both their physical and emotional recovery. This study shows that caring for emotional wellbeing through counseling, mindfulness, and community support can profoundly enhance recovery and quality of life for cancer patients.
Reflections and the Road Ahead
The evidence from recent studies published in BMC Series journals reinforces a powerful message: liver health is a lifelong responsibility. Understanding how our body functions is vital for prevention; maintaining healthy habits demands daily commitment; and caring for mental wellbeing is part of medical care. Strengthening awareness, early detection, and emotional support can help reduce the burden of liver cancer and promote collective wellbeing.
Follow the Topic
-
BMC Psychiatry
This is an open access, peer-reviewed journal that encompasses a wide range of topics, including psychopharmacology, psychotherapy, and psychosocial approaches to psychiatric disorders, as well as genetics, pathophysiology, and epidemiology research.
-
BMC Gastroenterology
This is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of gastrointestinal and hepatobiliary disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
-
BMC Cancer
This is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers.
Related Collections
With Collections, you can get published faster and increase your visibility.
Artificial intelligence in gastrointestinal diagnostics
The integration of artificial intelligence (AI) into gastrointestinal diagnostics is a step toward enhancing the accuracy and efficiency of disease detection and management. By leveraging machine learning algorithms and advanced computational techniques, researchers and clinicians are able to analyze complex datasets, including imaging and pathology results. This Collection aims to explore the applications of AI in the field of gastroenterology, focusing on its potential to improve diagnostic outcomes and patient care.
The significance of AI in gastrointestinal diagnostics is underscored by recent developments in early cancer detection and the management of gastrointestinal diseases. AI-driven tools have demonstrated the capability to assist in identifying abnormalities in endoscopic images, predicting disease progression, and personalizing treatment strategies. Continued research in this area could pave the way for incremental developments, such as real-time AI-assisted diagnostic tools that improve clinician decision-making and patient care. Future research may include the refinement of AI algorithms for more accurate risk stratification, comprehensive assessments, and the establishment of robust AI frameworks that ensure ethical and equitable access to advanced diagnostic technologies.
Topics of interest include, but are not limited to:
- AI applications in endoscopic imaging
- Machine learning for early cancer detection
- Pathology and AI integration
- AI-driven diagnostics in gastrointestinal diseases
- Predictive analytics for disease progression in gastroenterology
- Natural language processing in clinical documentation and diagnosis
- AI-enhanced decision support systems for clinicians
- The role of AI in patient monitoring and management
- Ethical considerations in AI implementation in gastroenterology
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Oct 14, 2026
Obesity, metabolic syndrome, and gastrointestinal disorders
Obesity and metabolic syndrome are growing global health concerns, intricately linked with various gastrointestinal disorders. These conditions are characterised by the accumulation of excess fat, insulin resistance, and dyslipidaemia, all of which can exacerbate gastrointestinal health issues such as gastroesophageal reflux disease, inflammatory bowel disease, and non-alcoholic fatty liver disease. Understanding the interplay between obesity, metabolic disorders, and gastrointestinal health is critical for developing effective prevention and treatment strategies.
Research in this domain has advanced significantly in recent years, uncovering the complex mechanisms that connect obesity and metabolic syndrome to gastrointestinal disorders. Studies have shown that alterations in gut microbiota, inflammatory pathways, and metabolic signalling can play pivotal roles in disease progression. Additionally, the exploration of lifestyle interventions, pharmacological treatments, and surgical options has illuminated potential avenues for improving patient outcomes. This is especially pertinent as obesity rates continue to rise, necessitating a deeper understanding of its impacts on gastrointestinal health.
Looking forward, ongoing investigation into the molecular and environmental factors contributing to these interrelated conditions may yield significant breakthroughs. Future research may uncover novel biomarkers for early diagnosis and effective management strategies, as well as tailored therapeutic approaches that consider individual patient profiles. Leveraging advancements in technology, such as microbiome analysis and metabolic profiling, holds promise for enhancing our understanding of these complex interactions and could fundamentally shift treatment paradigms.
Topics of interest include, but are not limited to:
- Impact of obesity on gastrointestinal disorders
- Metabolic syndrome and digestive health
- The role of gut microbiota in metabolic disorders
- Lifestyle interventions for gastrointestinal health
- Pharmacological advancements in obesity treatment
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Apr 27, 2027
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in